Profarma Recalls tabcin NOCHE Capsules Due to Manufacturing Deviations
Profarma Distributors LLC is recalling 31 boxes of tabcin NOCHE capsules nationwide due to Current Good Manufacturing Practice (CGMP) deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to CGMP deviations, which typically indicates a risk of temporary or medically reversible adverse health consequences, fitting the Moderate severity criteria for low-risk contamination or voluntary precautionary recalls without reported serious injury.
Plain-English summary
Profarma Distributors LLC is voluntarily recalling 31 boxes (372 capsules) of tabcin NOCHE capsules, 12-count boxes. The affected product is identified by Lot # X223FS and an expiration date of 11/17. The recall was initiated on May 11, 2016, and the product was distributed nationwide.
The reason for the recall is Current Good Manufacturing Practice (CGMP) deviations. The FDA has classified this recall as Class II, which indicates a situation that may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. The recall was initiated by the firm and was terminated on January 24, 2017.
Consumers who have the affected product should stop using it and contact Profarma Distributors LLC for further instructions. The recall status is currently terminated.
The recalled product
- Product
- tabcin NOCHE; Capsules,12-count box, UPC 501008485033
- Manufacturer
- Profarma Distributors LLC
- Category
- Drug — Pharmaceutical
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # X223FS
- Exp. 11/17
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Profarma Distributors LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Profarma Distributors LLC
See all →- ModerateProfarma Recalls Vermox Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2016-06-29
- ModerateProfarma Recalls tabcin ACTIVE M.R. Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2016-06-29
- ModerateProfarma Recalls Vermox Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2016-06-29
- ModerateProfarma Recalls 1% Clotrimazole Cream Due to Manufacturing Deviations
FDA (Drugs) · 2016-06-29
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- SevereShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19